sopharma - Najnowsze wiadomości
2025-12-03 13:00SOPHARMA AD: Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" ADSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Donev investments holding_Sopharma_EN_2025.12.02Buy.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-03 09:26SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_235_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-02 15:15SOPHARMA AD: Notification from Donev Investments Holding AD in accordance with Regulation 596/2014 for transactions with shares of Sopharma ADSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Donev investments holding_Sopharma_EN_2025.12.01Buy.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-02 13:29SOPHARMA AD: Notification from Ognian Donev in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" ADSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Donev_Sopharma_EN_01122025.Buy.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word;...
2025-12-02 08:53SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_232_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-12-01 09:49SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_231_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-28 13:59SOPHARMA AD: Consolidated financial statements for the nine months of 2025Spis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_Q3_2025_cons_Financial statements.rar td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word;...
2025-11-28 09:28SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_229_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-27 09:14SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_228_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-26 09:32SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_227_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-25 13:58SOPHARMA AD: Notification for sale of trasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_226_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-25 09:39SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_225_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-20 13:11SOPHARMA AD: Notification for sales revenues for OctoberSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:SFA_Sales_Revenues_October_2025_EN_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-18 15:29SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_223_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-17 10:01SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_222_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-12 10:32SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_221_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-07 12:46SOPHARMA AD: Publication of a document prepared in accordance with Article 1(5)(ba) of Regulation (EU) 2017/1129Spis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Exemption document 07112025.rar td.td-text, th.td-text { word-break: keep-all; overflow-wrap: break-word;...
2025-11-07 09:43SOPHARMA AD: Notification for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_219_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...
2025-11-06 09:23SOPHARMA AD: Notitfication for sale of treasury sharesSpis treści:1. REPORT2. INFORMATION ABOUT THE ENTITY3. SIGNATURE OF PERSONS REPRESENTING THE COMPANYSpis załączników:Current report_218_treasury_shares_espi.pdf td.td-text, th.td-text { word-break: keep-all; overflow-wrap:...